1. Track 303: Leukemia, Lymphoma, and Chronic Myeloblastic Leukemia.

2. JANEX-1 exhibits significant anti-leukemia activity, which could induce apoptosis in human lymphoblastic as well as myeloblastic leukemia cells with over-expressed tyrosine protein kinase.

3. Objective:To study the correlation between cytotoxicity of daunorubicine (DNR) and harringtonine (H) to leukemic cells in vitro from 39 patients with acute myeloblastic leukemia (AML).

4. Objective To investigate the effects of quercetin on cell morphology and VEGF expression of acute myeloblastic leukemia cells NB4 in vitro.

5. Objective: To study the sensitivity in vitro and the interaction of drugs in combination chemotherapy for acute myeloblastic leukemia (AML).